
浏览全部资源
扫码关注微信
纸质出版日期:2013
移动端阅览
王宇亮, 党中勤, 张广玉, 等. 中医多途径给药对重型肝炎患者肠黏膜通透性及内毒素、血氨的影响[J]. 中国实验方剂学杂志, 2013,19(16):297-301.
WANG Yu-liang, DANG Zhong-qin, ZHANG Guang-yu, et al. Effect of Intestinal Mucosa Permeability,Endotoxin Blood and Ammonia of Severe Hepatitis Treated with Multi-ways Administration of Chinese Medicine[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 297-301.
王宇亮, 党中勤, 张广玉, 等. 中医多途径给药对重型肝炎患者肠黏膜通透性及内毒素、血氨的影响[J]. 中国实验方剂学杂志, 2013,19(16):297-301. DOI: 10.11653/syfj2013160297.
WANG Yu-liang, DANG Zhong-qin, ZHANG Guang-yu, et al. Effect of Intestinal Mucosa Permeability,Endotoxin Blood and Ammonia of Severe Hepatitis Treated with Multi-ways Administration of Chinese Medicine[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 297-301. DOI: 10.11653/syfj2013160297.
目的: 研究中医多途径给药对重型肝炎患者肠黏膜通透性及内毒素的影响。 方法: 将88例重型肝炎病人按就诊顺序随机分为治疗组57例
对照组31例。对照组采用西医常规护肝、支持疗法及人工肝治疗
治疗组在上述基础上加用中医多途径序贯给药
包括中药保留灌肠、中药穴位贴敷、辨证口服中药、中成药静脉滴注等。 结果: 治疗组57例中
临床治愈16例
显效17例
有效14例
无效10例
总有效率82.46%;对照组31例中
临床治愈3例
显效7例
有效9例
无效12例
总有效率61.29%;两组疗效比较有显著性差异(P<0.05)
治疗组疗效优于对照组。两组患者出现感染几率及住院治疗时间、应用人工肝治疗次数比较
治疗组均显著优于对照组(P<0.05)。 结论: 中医多途径序贯给药可减少重型肝炎患者感染发生率
显著提高西医常规疗法治疗重型肝炎的临床疗效
缩短患者住院治疗时间
减少人工肝治疗次数
降低医疗费用
是值得临床推广的优化治疗方案。
Objective: To study the effect of intestinal mucosa permeability
endotoxin blood and ammonia of Severe hepatitis treated with multi-ways administration of Chinese medicine. Method: Eighty-eight severe hepatitis patients were randomLy distributed into therapy group (57 cases)and control group(31 cases). According to clinic sequence
the control group was treated with conventional therapy methods such as protecting liver
supporting treatment and artificial liver support system
in the same time the therapy group was treated with conventional therapy plus multi-ways administration of Chinese medicine such as retention enema
sticking
oral administration dialectically and intravenous drip with traditional Chinese medicine. Result: The total effective rate was 82.46% in the therapy group
in which 16 cases were obviously improved
18 cases were improved
7 cases were ineffective and 1 case was sheded; whereas the total effective rate was 61.29% in the control group
in which 3 were cases cured
7 cases were obviously improved
9 cases were improved
12 cases were ineffective
and 2 cases were sheded. The difference between the two groups was obvious (P<0.05)
with the treatment group being better than the control group.A obvious difference(P<0.05) was exhibited in refractory complications
time of hospitalization
number of times of artificial liver treatment
with the treatment group being better than the control group. Conclusion: Multi-ways administration of Chinese medicine could promote the recovery of severe hepatitis patients
reduce the refractory complications
cost
time of hospitalization and the number of times of artificial liver treatment of severe hepatitis patients
thus is a valuable optimization treatment method.
0
浏览量
4
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621